Clinical Test Presentations

This presentation provides an overview of the clinical importance of Helicobacter pylori infection and the role of stool antigen testing in its detection and management. It introduces the Biopanda H. pylori Antigen Rapid Test as a reliable, non-invasive diagnostic tool, highlighting its clinical utility, performance characteristics, and relevance for routine use in healthcare and laboratory settings. 

This presentation provides an educational overview of D-dimer and its clinical relevance in the assessment of thrombotic conditions such as DVT, PE, and DIC, alongside a practical explanation of the Biopanda D-dimer Rapid Test. It also highlights the test’s performance characteristics, workflow, and key commercial advantages, positioning it as a reliable point-of-care screening tool for healthcare settings. 

This presentation introduces Biopanda’s HIV, HBsAg, HCV & Syphilis Combo Rapid Test as a low-cost, easy-to-use point-of-care solution for simultaneous screening of four major blood-borne and sexually transmitted infections. It highlights the clinical importance of integrated testing, the test’s strong performance and ISO 13485 manufacturing quality, and its value to distributors and healthcare professionals in streamlining workflows and expanding access to timely diagnosis. 

This presentation focuses on the Biopanda point-of-care screening test for the qualitative detection of HbA, HbS, and HbC, supporting early identification of sickle cell disease and related haemoglobin variants. Sickle cell disease refers to a group of inherited disorders affecting red blood cells, with sickle cell anaemia being the most severe form. 

This presentation gives distributors a concise overview of the Biopanda Syphilis Rapid Test Cassette, covering its clinical purpose, test principle, workflow, and key performance data. It is designed to support effective product training and confident positioning of the test as a rapid, reliable syphilis screening solution. 

This presentation provides an engaging overview of HIV infection and highlights the clinical advantages of the Biopanda HIV 1/2 Rapid Test Cassette, showcasing its high performance, ease of use, and value in point-of-care and laboratory settings. 

This presentation introduces the Biopanda HAV IgG/IgM Rapid Test, highlighting its clinical value, ease of use, and strong performance characteristics. It serves as both a sales support tool for distributors and an educational guide for healthcare professionals performing HAV antibody testing.

This presentation explains the clinical role of Cardiac Troponin I as a highly specific biomarker for myocardial infarction and demonstrates how the Biopanda Cardiac Troponin I Rapid Test can be used by healthcare professionals to support rapid, informed clinical decision-making in acute cardiac care settings. 

This presentation highlights the clinical importance of faecal occult blood testing for early detection of gastrointestinal disease with the assistance of the Biopanda FOB Rapid Test as a reliable, accurate, and easy-to-use FIT solution that delivers clear clinical value for healthcare professionals. 

This presentation provides an overview of Brucella abortus infection in humans, highlights the regions most affected by the disease, and explains the clinical value of rapid lateral flow antigen testing in supporting timely and accurate diagnosis. 

This presentation provides an overview of Biopanda Strep A Rapid Tests, highlighting the clinical importance of timely Strep A detection, the benefits of rapid point-of-care testing, and how these easy-to-use, reliable assays support effective patient management, antimicrobial stewardship, and efficient workflows in a variety of healthcare settings. 

This presentation focuses on the Biopanda Filariasis IgG/IgM Rapid Test and how screening for lymphatic filariasis LF it enables the early identification of exposure or infection in individuals who may be asymptomatic, supporting timely clinical assessment, targeted intervention, and effective surveillance in endemic and at-risk populations. 

This presentation focuses on the Biopanda HPV Antigen Rapid Test and how screening for human papilloma virus at point-of-care settings, such as doctor's clinics etc. can assist in the early detection of HPV infections which can cause cancer. 

This presentation focuses on the Biopanda Fluorescence Immunoassay Device and utilising the tests for point-of-care settings such as doctor's clinics, pharmacies, emergency department, nursing homes, etc. 

This presentation focuses on the importance of testing for inflammatory markers at the point-of-care setting, focusing on CRP but also looking at other important biomarkers such as IL-6, PCT, and SAA, and how the Biopanda Fluorescence Immunoassay range of tests can assist with fast and effective diagnosis. 

This presentation focuses on the importance of combined testing for respiratory infections and how the Biopanda COVID-19  and Influenza A+B Ag Combo Rapid Test can assist with fast and effective diagnosis. 

This presentation focuses on the use of the H-FABP/cTnI Rapid test in clinical setting and why testing for cardiac biomarkers at the point of care setting improves patient diagnosis and treatment. 

This presentation focuses on the importance of multiplex testing for respiratory infections and how the Biopanda COVID-19 / Influenza A+B / RSV / Adenovirus / M. pneumoniae Antigen Combo Rapid Test can assist with fast and effective diagnosis. 

This presentation focuses on the importance importance of Lateral Flow testing for the diagnosis of Gut health conditions.